美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA217180"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
50881-044-08 50881-044 HUMAN PRESCRIPTION DRUG JAKAFI XR ruxolitinib TABLET, EXTENDED RELEASE ORAL 20260501 N/A NDA NDA217180 Incyte Corporation RUXOLITINIB 44 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08)
50881-022-08 50881-022 HUMAN PRESCRIPTION DRUG JAKAFI XR ruxolitinib TABLET, EXTENDED RELEASE ORAL 20260501 N/A NDA NDA217180 Incyte Corporation RUXOLITINIB 22 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08)
50881-033-08 50881-033 HUMAN PRESCRIPTION DRUG JAKAFI XR ruxolitinib TABLET, EXTENDED RELEASE ORAL 20260501 N/A NDA NDA217180 Incyte Corporation RUXOLITINIB 33 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-033-08)
50881-011-08 50881-011 HUMAN PRESCRIPTION DRUG JAKAFI XR ruxolitinib TABLET, EXTENDED RELEASE ORAL 20260501 N/A NDA NDA217180 Incyte Corporation RUXOLITINIB 11 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-011-08)
50881-055-08 50881-055 HUMAN PRESCRIPTION DRUG JAKAFI XR ruxolitinib TABLET, EXTENDED RELEASE ORAL 20260501 N/A NDA NDA217180 Incyte Corporation RUXOLITINIB 55 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-055-08)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase